Also trades as: NHNKY (OTC) · $vol 0M · NHNKF (OTC) · $vol 0M

¥1,582.50 ($10.03)

+20.00 (+1.28%)

Weekly Expected Move ±3.3%

¥1461 ¥1512 ¥1562 ¥1613 ¥1664

JPX · Healthcare · Medical - Devices · Tech Score Buy · Power 63 · ¥250.0B mcap · 158M float · 0.469% daily turnover

Revenue

$235.1B +4.3% ▲

5Y CAGR: +3.3%

Gross Profit

$118.0B +3.2% ▲

5Y CAGR: +2.9%

Operating Income

$18.8B -9.3% ▼

5Y CAGR: -7.1%

Net Income

$14.5B +3.0% ▲

5Y CAGR: -4.5%

EPS (Diluted)

$89.25 +5.2% ▲

5Y CAGR: -3.6%

EBITDA

$26.1B +0.7% ▲

5Y CAGR: -3.8%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$205.1B	$206.6B	$222.0B	$225.4B	$235.1B
YoY Growth	+2.7%	+0.7%	+7.4%	+1.5%	+4.3%
Cost of Revenue	$96.0B	$100.7B	$110.6B	$111.1B	$117.1B
Gross Profit	$109.1B	$105.9B	$111.3B	$114.3B	$118.0B
Gross Margin	53.2%	51.3%	50.2%	50.7%	50.2%
R&D Expenses	$5.7B	$6.2B	$7.0B	$6.8B	$7.5B
SG&A Expenses	$70.0B	$75.9B	$82.0B	$86.8B	$91.8B
Operating Expenses	$78.1B	$84.8B	$91.8B	$93.6B	$99.2B
Operating Income	$31.0B	$21.1B	$19.6B	$20.7B	$18.8B
Operating Margin	15.1%	10.2%	8.8%	9.2%	8.0%
Interest Expense	$11M	$10M	$24M	$144M	$341M
Income Before Tax	$34.3B	$24.7B	$29.4B	$21.6B	$19.9B
Tax Expense	$10.8B	$7.6B	$12.3B	$7.5B	$5.4B
Net Income	$23.4B	$17.1B	$17.0B	$14.1B	$14.5B
Net Margin	11.4%	8.3%	7.7%	6.3%	6.2%
EPS (Diluted)	$138.26	$101.64	$101.22	$84.87	$89.25
EBITDA	$37.8B	$28.5B	$33.2B	$24.9B	$26.1B
Shares Outstanding	168M	168M	168M	166M	163M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$46.2B	$56.6B	$55.7B	$66.9B	$50.0B	$58.1B	$55.9B	$71.1B
Cost of Revenue	$24.4B	$26.5B	$25.2B	$32.2B	$23.7B	$27.6B	$27.6B	$36.1B
Gross Profit	$21.9B	$30.1B	$30.5B	$34.7B	$26.3B	$30.5B	$28.3B	$35.0B
Gross Margin	47.3%	53.1%	54.8%	51.9%	52.6%	52.5%	50.6%	49.2%
R&D Expenses	$1.6B	$1.6B	$0	$1.9B	$1.6B	$1.8B	$1.9B	$2.2B
SG&A Expenses	$21.5B	$22.1B	$24.7B	$23.1B	$23.3B	$23.4B	$23.9B	$24.8B
Operating Expenses	$23.1B	$23.7B	$24.7B	$24.9B	$24.9B	$25.1B	$25.9B	$27.0B
Operating Income	-$1.2B	$6.4B	$5.8B	$9.8B	$1.4B	$5.3B	$2.4B	$8.0B
Operating Margin	-2.7%	11.2%	10.5%	14.6%	2.8%	9.2%	4.3%	11.2%
Interest Expense	$8M	$8M	$35M	$93M	$107M	$39M	$83M	$112M
Income Before Tax	$1.7B	$240M	$11.4B	$8.3B	$472M	$6.3B	$3.1B	$10.1B
Tax Expense	$902M	$543M	$3.7B	$2.3B	$278M	$1.9B	$1.3B	$1.9B
Net Income	$766M	-$303M	$7.7B	$6.0B	$138M	$4.4B	$1.9B	$8.1B
Net Margin	1.7%	-0.5%	13.8%	8.9%	0.3%	7.6%	3.4%	11.4%
EPS (Diluted)	$4.57	$-1.81	$46.58	$36.56	$0.84	$26.90	$11.57	$49.94
EBITDA	$2.1B	$7.4B	$6.9B	$9.6B	$1.6B	$7.4B	$4.7B	$11.8B
Shares Outstanding	168M	167M	165M	163M	163M	163M	163M	162M

6849.T JPX